KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Accumulated Expenses (2016 - 2026)

Medtronic (MDT) has disclosed Accumulated Expenses for 13 consecutive years, with $2.6 billion as the latest value for Q1 2026.

  • Quarterly Accumulated Expenses rose 13.15% to $2.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Jan 2026, up 13.15% year-over-year, with the annual reading at $2.5 billion for FY2025, 5.85% up from the prior year.
  • Accumulated Expenses hit $2.6 billion in Q1 2026 for Medtronic, up from $2.1 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.6 billion in Q1 2026 to a low of $1.7 billion in Q3 2023.
  • Historically, Accumulated Expenses has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2025.
  • Biggest five-year swings in Accumulated Expenses: fell 14.54% in 2022 and later grew 21.86% in 2024.
  • Year by year, Accumulated Expenses stood at $1.7 billion in 2022, then grew by 2.15% to $1.8 billion in 2023, then rose by 7.68% to $1.9 billion in 2024, then increased by 12.52% to $2.1 billion in 2025, then grew by 21.17% to $2.6 billion in 2026.
  • Business Quant data shows Accumulated Expenses for MDT at $2.6 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.0 billion in Q3 2025.